Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma

M.A. Izquierdo, A. van der Zee, J.B. Vermorken, P. van der Valk, J.A.M. van der Beliën, G. Giaccone, G.L. Scheffer, M.J. Flens, H.M. Pinedo, P. Kenemans, C.J.L.M. Meijer, E.G.E. de Vries, R.J. Scheper

Research output: Contribution to journalArticleAcademicpeer-review

41 Downloads (Pure)
Original languageEnglish
Pages (from-to)1230-1237
JournalJournal of the National Cancer Institute
Volume87
Publication statusPublished - 1995

Cite this

Izquierdo, M. A., van der Zee, A., Vermorken, J. B., van der Valk, P., van der Beliën, J. A. M., Giaccone, G., ... Scheper, R. J. (1995). Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. Journal of the National Cancer Institute, 87, 1230-1237.